Ren Luo

9PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapySynchrotrons and accelerators not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2026
SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8<sup>+</sup> T cell immunity against bulky tumors via an IFN-I/NK/DC axis.

|Jun 09, 2026
Tumor-Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy-Immunotherapy Combination Trials.

|Feb 10, 2026
CD4<sup>+</sup> T cells facilitate the RT-induced abscopal effect by promoting antigen cross-presentation to CD8<sup>+</sup> T cells at unirradiated tumor sites.

Xi Rao, Kateryna Onyshchenko, Meidan Wang

|Aug 05, 2024
Author Correction: Expansion of circulating stem-like CD8<sup>+</sup> T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice.

Kateryna Onyshchenko, Ren Luo, Elena Guffart

|Jun 12, 2024
Real-World Survival Comparisons Between Radiotherapy and Surgery for Metachronous Second Primary Lung Cancer and Predictions of Lung Cancer-Specific Outcomes Using Machine Learning: Population-Based Study.

Yue Zheng, Ailin Zhao, Yuqi Yang

|Aug 28, 2023
Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.

Liqun Wang, Ren Luo, Kateryna Onyshchenko

Pageof 2

Frequent Collaborators

4 joint publications

Kateryna Onyshchenko

4 joint publications

Gabriele Niedermann

2 joint publications

Jianxin Xue

1 joint publications

Yizhou Yang